Home › Competition springing up for Humira, AbbVie's hot-selling drug
 

Keywords :   


Competition springing up for Humira, AbbVie's hot-selling drug

2015-10-14 23:38:20| Agriculture - Topix.net

Another week, and another competitor is nipping at the heels of AbbVie Inc.'s rheumatoid arthritis treatment Humira, the top-selling drug in the world. This time it's Eli Lilly and its biotech partner Incyte Corp., which on Wednesday announced that their experimental drug baricitinib proved superior to Humira in a large study, raising questions about whether AbbVie of North Chicago can protect a product that generated $12.5 billion in sales last year.

Tags: drug competition humira hotselling

Category:Agriculture and Forestry

Latest from this category

All news
17.11UNL to study cattle impacts on climate change
16.11Integration of value-added beef nutrition programs into daily operation
16.11This Week in Agribusiness, Nov. 16, 2024
16.11This Week in Agribusiness, Nov. 16, 2024
15.11Global beef roundup: Focus on Brazil, Part 2
15.112024 NAPRRS/NC229 session to address emerging swine diseases
15.11Beef, dairy producers invited to Purdue Calving Academy
15.11The long grind
Agriculture and Forestry »
18.11
18.11
18.11 1-23
18.1138explore TheArth
18.11SnowMan
18.11BOSS EZO FUKUOKA 3000x2
18.11: DNA DVD-BOX
18.11A0079
More »